Abstract
AbstractEffective gene therapy for diseases of the circulation requires vectors capable of systemic delivery. The molecular weight of poly(l-lysine) (pLL) has a significant effect on the circulation of pLL/DNA complexes in mice, with pLL211/DNA complexes displaying up to 20 times greater levels in the blood after 30 minutes compared with pLL20/DNA. It is shown that pLL20/DNA complexes fix mouse complement C3 in vitro, independent of immunoglobulin binding; are less soluble in the blood in vivo; bind erythrocytes; are rapidly removed by the liver, where they associate predominantly with Kupffer cells; and result in a rapid increase in hepatic leukocytes expressing high levels of complement receptor 3 (CR3). The circulation properties of these complexes are also dependent on the type of DNA used, with circular plasmid DNA complexes exhibiting increased circulation compared with linear DNA. PLL211/DNA complexes bind erythrocytes and associate with Kupffer cells but, in contrast, do not fix mouse complement in vitro and are unaffected by the type of DNA used. In rats, both types of complexes produce hematuria and are rapidly removed from the circulation. Correlation of in vivo and in vitro results suggests that the solubility of complexes in physiological saline and species-matched complement fixation and erythrocyte lysis may correlate with systemic circulation. Analysis using human blood in vitro shows no hemolysis, but both types of complexes fix complement and bind IgG, suggesting that pLL/DNA complexes may be rapidly cleared from the human circulation.
References
40
Referenced
157
10.1358/dot.1999.35.11.562557
/ Drugs Today. / Cystic fibrosis: a decade of progress. by Allen (1999)10.1136/gut.46.3.344
/ Gut. / Interleukin 10 gene transfer prevents experimental colitis in rats. by Barbara (2000)10.1038/sj.gt.3301076
/ Gene Ther. / Glucose regulated production of human insulin in rat hepatocytes. by Thule (2000)10.1067/mlc.2000.104458
/ J Lab Clin Med. / Gene therapy for chronic granulomatous disease. by Kume (2000)10.1358/dot.1999.35.12.564039
/ Drugs Today. / The potential use of gene therapy in the control of hypertension. by Gardon (1999)10.1096/fasebj.14.2.301
/ FASEB J. / An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. by Yoon (2000)10.1089/10430349950016375
/ Hum Gene Ther. / Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases. by Dow (1999)10.1038/sj.gt.3300719
/ Gene Ther. / The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. by Xu (1998)10.1073/pnas.88.10.4255
/ Proc Natl Acad Sci U S A. / Transferrin polycation DNA complexes—the effect of polycations on the structure of the complex and delivery to cells. by Wagner (1991)10.1073/pnas.89.17.7934
/ Proc Natl Acad Sci U S A. / Influenza-virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin polylysine DNA complexes—toward a synthetic virus-like gene-transfer vehicle. by Wagner (1992)10.1089/hum.1994.5.9-1095
/ Hum Gene Ther. / Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein polylysine DNA complexes. by Stankovics (1994)10.1016/S0169-409X(97)00110-5
/ Adv Drug Delivery Rev. / Polylysine-based transfection systems utilising receptor-mediated delivery. by Zauner (1998)10.1038/sj.gt.3300843
/ Gene Ther. / Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. by Dash (1999)10.1016/S0168-3659(97)00263-0
/ J Controlled Release. / Targeted delivery of plasmid DNA complexes with galactosylated poly(L-lysine). by Hashida (1998)10.1016/S0167-4781(98)00274-7
/ Biochim Biophys Acta. / Stabilisation of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. by Kwoh (1999)10.3109/10611860009009207
/ J Drug Target. / Pharmacokinetics and in vivo gene transfer of plasmid DNA complexes with mannosylated poly(L-lysine) in mice. by Nishikawa (2000)10.1074/jbc.274.8.4908
/ J Biol Chem. / Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. by Ziady (1999)10.1089/hum.1996.7.12-1437
/ Hum Gene Ther. / Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. by Plank (1996)10.1084/jem.142.3.709
/ J Exp Med. / Interactions of C-reactive protein with the complement system, II: C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. by Siegal (1975){'key': '2020021218384551200_B20', 'first-page': '269', 'article-title': 'Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA.', 'volume': '3', 'author': 'Wolfert', 'year': '1996', 'journal-title': 'Gene Ther.'}
/ Gene Ther. / Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA. by Wolfert (1996){'key': '2020021218384551200_B21', 'volume-title': 'Guidance on the Operation of the Animals (Scientific Procedures Act) 1986. London', 'author': 'Home Office', 'year': '1986'}
/ Guidance on the Operation of the Animals (Scientific Procedures Act) 1986. London by Home Office (1986)10.1016/S0927-7765(99)00076-4
/ Colloids Surfaces B. / Turbidometric analysis of polyelectrolyte complexes formed between poly(L-lysine) and DNA. by Ward (1999)10.1038/sj.gt.3300900
/ Gene Ther. / pEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. by Ogris (1999){'key': '2020021218384551200_B24', 'first-page': '451', 'article-title': 'Measurement of the immunoperoxidase staining of macrophages within liver granulomata of mice infected with Mycobacterium tuberculosis.', 'volume': '14', 'author': 'Orrell', 'year': '1992', 'journal-title': 'Anal Quant Cytol Histol.'}
/ Anal Quant Cytol Histol. / Measurement of the immunoperoxidase staining of macrophages within liver granulomata of mice infected with Mycobacterium tuberculosis. by Orrell (1992)10.1016/S0162-3109(99)00157-5
/ Immunopharmacology. / Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonised erythrocytes or soluble beta-glucan. by Yan (2000)10.1111/j.1365-2249.1993.tb03377.x
/ Clin Exp Immunol. / CR3 (CD11b/CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. by Ross (1993)10.4049/jimmunol.163.6.3045
/ J Immunol. / Beta-glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leucocyte complement receptor type 3 (CD11b/CD18). by Yan (1999){'key': '2020021218384551200_B28', 'first-page': '460', 'article-title': 'Regulation of human neutrophil type 3 receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli.', 'volume': '67', 'author': 'Gordon', 'year': '1989', 'journal-title': 'Immunology.'}
/ Immunology. / Regulation of human neutrophil type 3 receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli. by Gordon (1989)10.4049/jimmunol.135.4.2668
/ J Immunol. / Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages. by Rothlein (1985)10.4049/jimmunol.162.4.2281
/ J Immunol. / The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. by Xia (1999)10.1016/0161-5890(90)90041-W
/ Mol Immunol. / Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells. by Klein (1990)10.1016/S0014-5793(96)01197-0
/ FEBS Lett. / Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. by Takizawa (1996)10.1016/S0168-3659(99)00089-9
/ J Controlled Release. / Effect of DNA topology on the transfection efficiency of poly(2-dimethylamino)ethyl methacrylate)-plasmid complexes. by Cherng (1999)10.1089/hum.1998.9.3-315
/ Hum Gene Ther. / Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid DNA complexes. by Barron (1998)10.1177/019262339902700102
/ Toxicol Pathol. / Preclinical development strategies for novel gene therapeutic products. by Pilaro (1999)10.1111/j.1748-1716.1982.tb07060.x
/ Acta Physiol Scand. / Plasma and red cell volumes of microwave irradiated mice tissues. by Virkkunen (1982)10.1016/0022-1759(94)90081-7
/ J Immunol Methods. / Quantitation of epsilon-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid: a simple spectrophotometric method for the estimation of hapten to carrier protein ratio. by Sashidhar (1994){'key': '2020021218384551200_B38', 'first-page': '141', 'article-title': 'Estimation of avidin activity by two methods.', 'volume': '42', 'author': 'Borza', 'year': '1991', 'journal-title': 'Rev Roum Virol.'}
/ Rev Roum Virol. / Estimation of avidin activity by two methods. by Borza (1991)10.1002/jbm.820211106
/ J Biomed Mater Res. / Effect of molecular weight (Mw) of N-(2hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. by Seymour (1987)10.1038/bjc.1991.190
/ Br J Cancer. / N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. by Seymour (1991)
Dates
Type | When |
---|---|
Created | 23 years ago (July 27, 2002, 8:46 a.m.) |
Deposited | 1 year, 7 months ago (Jan. 6, 2024, 1:42 a.m.) |
Indexed | 19 hours, 42 minutes ago (Aug. 23, 2025, 9:48 p.m.) |
Issued | 24 years, 4 months ago (April 15, 2001) |
Published | 24 years, 4 months ago (April 15, 2001) |
Published Print | 24 years, 4 months ago (April 15, 2001) |
@article{Ward_2001, title={Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy}, volume={97}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v97.8.2221}, DOI={10.1182/blood.v97.8.2221}, number={8}, journal={Blood}, publisher={American Society of Hematology}, author={Ward, Christopher M. and Read, Martin L. and Seymour, Leonard W.}, year={2001}, month=apr, pages={2221–2229} }